Kestra Medical Technologies (KMTS) Operating Leases (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Operating Leases data on file, last reported at $4.1 million in Q2 2026.

• On a quarterly basis, Operating Leases rose 35.86% year-over-year to $4.1 million in Q2 2026; TTM through Apr 2026 was $4.1 million, a 35.86% increase from a year earlier, with the FY2026 full-year figure at $4.1 million, up 35.86% from the prior year.
• Operating Leases for Q2 2026 stood at $4.1 million, down from $4.3 million in the prior quarter.
• Over the last five years, Operating Leases for KMTS reached as high as $4.3 million in Q1 2026 and fell as low as $2.6 million in Q2 2024.
• Historically, Operating Leases has averaged $3.3 million across 3 years, with a median of $3.0 million in 2025.
• Across the five-year window, Operating Leases advanced 14.93% in 2025 and soared 49.41% in 2026, its largest moves.
• Year by year, Operating Leases stood at $2.6 million in 2024, then climbed by 9.15% to $2.9 million in 2025, then soared by 43.04% to $4.1 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $4.1 million in Q2 2026, $4.3 million in Q1 2026, and $2.9 million in Q4 2025.